AAPL325.50+8.65 (+2.73%) ▲|ABBV259.91+3.49 (+1.36%) ▲|ABT109.01-1.35 (-1.22%) ▼|ACN187.78-1.98 (-1.04%) ▼|ADBE286.13-6.66 (-2.27%) ▼|AMAT441.46-16.93 (-3.69%) ▼|AMD458.55-12.18 (-2.59%) ▼|AMGN436.55+6.67 (+1.55%) ▲|AMT175.22-0.48 (-0.27%) ▼|AMZN254.36-5.41 (-2.08%) ▼|AVGO369.85-0.49 (-0.13%) ▼|AXP324.87-5.30 (-1.61%) ▼|BA205.97-1.82 (-0.87%) ▼|BAC62.01+0.07 (+0.10%) ▲|BKNG196.38-2.71 (-1.36%) ▼|BLK1,132.28-23.33 (-2.02%) ▼|BMY66.79-0.03 (-0.04%) ▼|BNY160.30-0.98 (-0.61%) ▼|BRK-B502.70-1.34 (-0.26%) ▼|C132.61+0.99 (+0.75%) ▲|CAT778.76-18.71 (-2.35%) ▼|CL89.82-0.01 (-0.01%) ▼|CMCSA26.33-0.30 (-1.11%) ▼|COF211.23-3.28 (-1.53%) ▼|COP135.82+3.33 (+2.51%) ▲|COST936.41-7.48 (-0.79%) ▼|CRM258.02+0.48 (+0.19%) ▲|CSCO109.59-0.90 (-0.81%) ▼|CVS96.70+2.79 (+2.97%) ▲|CVX210.30+4.16 (+2.02%) ▲|DE673.95+19.04 (+2.91%) ▲|DHR207.18-6.38 (-2.99%) ▼|DIS106.39-1.16 (-1.08%) ▼|DUK120.14+0.23 (+0.19%) ▲|EMR147.64-4.80 (-3.15%) ▼|FDX322.27-5.14 (-1.57%) ▼|GD369.56-1.79 (-0.48%) ▼|GE331.05-4.66 (-1.39%) ▼|GEV896.11-2.42 (-0.27%) ▼|GILD149.03+2.69 (+1.83%) ▲|GM85.59-0.74 (-0.85%) ▼|GOOG331.48-3.93 (-1.17%) ▼|GOOGL334.61-4.74 (-1.40%) ▼|GS1,005.29-15.61 (-1.53%) ▼|HD319.07-8.76 (-2.67%) ▼|HON209.85-3.68 (-1.72%) ▼|IBM230.26-3.62 (-1.55%) ▼|INTC88.57-0.94 (-1.05%) ▼|INTU344.30-15.00 (-4.17%) ▼|ISRG367.60-9.27 (-2.46%) ▼|JNJ270.73+4.88 (+1.84%) ▲|JPM355.67-0.35 (-0.10%) ▼|KO88.02-0.65 (-0.73%) ▼|LIN486.14-3.44 (-0.70%) ▼|LLY1,158.16+1.43 (+0.12%) ▲|LMT542.26-15.53 (-2.78%) ▼|LOW199.52-5.18 (-2.53%) ▼|LRCX289.06-12.43 (-4.12%) ▼|MA583.23-6.08 (-1.03%) ▼|MCD261.59-0.09 (-0.03%) ▼|MDLZ61.48-0.59 (-0.95%) ▼|MDT91.91+1.26 (+1.39%) ▲|META579.87+7.53 (+1.32%) ▲|MMM170.62-1.21 (-0.70%) ▼|MO69.91+1.43 (+2.09%) ▲|MRK149.87+2.11 (+1.43%) ▲|MS211.78-1.55 (-0.72%) ▼|MSFT501.02-6.27 (-1.24%) ▼|MU930.78-27.95 (-2.92%) ▼|NEE82.57+0.23 (+0.28%) ▲|NFLX80.85-0.20 (-0.25%) ▼|NKE38.08-0.57 (-1.47%) ▼|NOW143.83-4.16 (-2.81%) ▼|NVDA217.62-2.88 (-1.31%) ▼|ORCL141.13-7.99 (-5.36%) ▼|PEP139.52-0.82 (-0.58%) ▼|PFE28.51+0.05 (+0.18%) ▲|PG146.39+1.27 (+0.88%) ▲|PLTR181.92-4.46 (-2.39%) ▼|PM188.48+1.18 (+0.63%) ▲|QCOM166.67-3.81 (-2.23%) ▼|RTX204.39-3.34 (-1.61%) ▼|SBUX105.66-0.60 (-0.56%) ▼|SCHW108.02-1.80 (-1.64%) ▼|SO88.11+0.11 (+0.12%) ▲|SPG211.67-0.65 (-0.31%) ▼|T26.13+0.24 (+0.93%) ▲|TMO601.80-15.30 (-2.48%) ▼|TMUS182.35+1.91 (+1.06%) ▲|TSLA356.16-11.80 (-3.21%) ▼|TXN253.08-7.83 (-3.00%) ▼|UBER75.22-0.43 (-0.57%) ▼|UNH395.79+6.38 (+1.64%) ▲|UNP288.95-11.72 (-3.90%) ▼|UPS102.51-1.72 (-1.65%) ▼|USB61.02-0.56 (-0.91%) ▼|V373.55-5.83 (-1.54%) ▼|VZ50.43+0.41 (+0.81%) ▲|WFC86.65+0.26 (+0.30%) ▲|WMT105.91+1.04 (+0.99%) ▲|XOM164.33+3.38 (+2.10%) ▲|AAPL325.50+8.65 (+2.73%) ▲|ABBV259.91+3.49 (+1.36%) ▲|ABT109.01-1.35 (-1.22%) ▼|ACN187.78-1.98 (-1.04%) ▼|ADBE286.13-6.66 (-2.27%) ▼|AMAT441.46-16.93 (-3.69%) ▼|AMD458.55-12.18 (-2.59%) ▼|AMGN436.55+6.67 (+1.55%) ▲|AMT175.22-0.48 (-0.27%) ▼|AMZN254.36-5.41 (-2.08%) ▼|AVGO369.85-0.49 (-0.13%) ▼|AXP324.87-5.30 (-1.61%) ▼|BA205.97-1.82 (-0.87%) ▼|BAC62.01+0.07 (+0.10%) ▲|BKNG196.38-2.71 (-1.36%) ▼|BLK1,132.28-23.33 (-2.02%) ▼|BMY66.79-0.03 (-0.04%) ▼|BNY160.30-0.98 (-0.61%) ▼|BRK-B502.70-1.34 (-0.26%) ▼|C132.61+0.99 (+0.75%) ▲|CAT778.76-18.71 (-2.35%) ▼|CL89.82-0.01 (-0.01%) ▼|CMCSA26.33-0.30 (-1.11%) ▼|COF211.23-3.28 (-1.53%) ▼|COP135.82+3.33 (+2.51%) ▲|COST936.41-7.48 (-0.79%) ▼|CRM258.02+0.48 (+0.19%) ▲|CSCO109.59-0.90 (-0.81%) ▼|CVS96.70+2.79 (+2.97%) ▲|CVX210.30+4.16 (+2.02%) ▲|DE673.95+19.04 (+2.91%) ▲|DHR207.18-6.38 (-2.99%) ▼|DIS106.39-1.16 (-1.08%) ▼|DUK120.14+0.23 (+0.19%) ▲|EMR147.64-4.80 (-3.15%) ▼|FDX322.27-5.14 (-1.57%) ▼|GD369.56-1.79 (-0.48%) ▼|GE331.05-4.66 (-1.39%) ▼|GEV896.11-2.42 (-0.27%) ▼|GILD149.03+2.69 (+1.83%) ▲|GM85.59-0.74 (-0.85%) ▼|GOOG331.48-3.93 (-1.17%) ▼|GOOGL334.61-4.74 (-1.40%) ▼|GS1,005.29-15.61 (-1.53%) ▼|HD319.07-8.76 (-2.67%) ▼|HON209.85-3.68 (-1.72%) ▼|IBM230.26-3.62 (-1.55%) ▼|INTC88.57-0.94 (-1.05%) ▼|INTU344.30-15.00 (-4.17%) ▼|ISRG367.60-9.27 (-2.46%) ▼|JNJ270.73+4.88 (+1.84%) ▲|JPM355.67-0.35 (-0.10%) ▼|KO88.02-0.65 (-0.73%) ▼|LIN486.14-3.44 (-0.70%) ▼|LLY1,158.16+1.43 (+0.12%) ▲|LMT542.26-15.53 (-2.78%) ▼|LOW199.52-5.18 (-2.53%) ▼|LRCX289.06-12.43 (-4.12%) ▼|MA583.23-6.08 (-1.03%) ▼|MCD261.59-0.09 (-0.03%) ▼|MDLZ61.48-0.59 (-0.95%) ▼|MDT91.91+1.26 (+1.39%) ▲|META579.87+7.53 (+1.32%) ▲|MMM170.62-1.21 (-0.70%) ▼|MO69.91+1.43 (+2.09%) ▲|MRK149.87+2.11 (+1.43%) ▲|MS211.78-1.55 (-0.72%) ▼|MSFT501.02-6.27 (-1.24%) ▼|MU930.78-27.95 (-2.92%) ▼|NEE82.57+0.23 (+0.28%) ▲|NFLX80.85-0.20 (-0.25%) ▼|NKE38.08-0.57 (-1.47%) ▼|NOW143.83-4.16 (-2.81%) ▼|NVDA217.62-2.88 (-1.31%) ▼|ORCL141.13-7.99 (-5.36%) ▼|PEP139.52-0.82 (-0.58%) ▼|PFE28.51+0.05 (+0.18%) ▲|PG146.39+1.27 (+0.88%) ▲|PLTR181.92-4.46 (-2.39%) ▼|PM188.48+1.18 (+0.63%) ▲|QCOM166.67-3.81 (-2.23%) ▼|RTX204.39-3.34 (-1.61%) ▼|SBUX105.66-0.60 (-0.56%) ▼|SCHW108.02-1.80 (-1.64%) ▼|SO88.11+0.11 (+0.12%) ▲|SPG211.67-0.65 (-0.31%) ▼|T26.13+0.24 (+0.93%) ▲|TMO601.80-15.30 (-2.48%) ▼|TMUS182.35+1.91 (+1.06%) ▲|TSLA356.16-11.80 (-3.21%) ▼|TXN253.08-7.83 (-3.00%) ▼|UBER75.22-0.43 (-0.57%) ▼|UNH395.79+6.38 (+1.64%) ▲|UNP288.95-11.72 (-3.90%) ▼|UPS102.51-1.72 (-1.65%) ▼|USB61.02-0.56 (-0.91%) ▼|V373.55-5.83 (-1.54%) ▼|VZ50.43+0.41 (+0.81%) ▲|WFC86.65+0.26 (+0.30%) ▲|WMT105.91+1.04 (+0.99%) ▲|XOM164.33+3.38 (+2.10%) ▲|
26.9 C
New York
Tuesday, September 1, 2026

Tag: cell therapies

newssourceFORcompanyinformationcontent1releasesmarket

CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China’s NMPA

SHANGHAI, June 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that...

NEW EDGE LIVING, A LYON LIVING COMPANY, UNVEILS TRANSFORMATIVE ENHANCEMENTS AT CDA NATIONAL RESERVE, A GOLF, SPORTING AND WELLNESS DESTINATION REDEFINING THE PRIVATE RESIDENTIAL...

Multimillion-Dollar Investment Delivers New Adventure Amenities, Mountain Modern Real Estate Offerings and an Innovative Partnership with Renowned Integrative Medical Practice Clinic 5C COEUR D'ALENE, Idaho,...

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management team will participate in the H.C. Wainwright “HCW@Home” Series taking place virtually on Wednesday, June 25, 2025, at 12:00 PM ET.

New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential

Press Release

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline |...

The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine...

CD5 Targeted Therapies CD5 Targeting CAR T Cell Therapy Clinical Trials Market Insight 2025

First CD5 Targeted Therapy Commercial Launch Expected By 2030 Says Kuick Research 
First CD5 Targeted Therapy Commercial Launch Expected By 2030 Says Kuick Research

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

If approved, Zemcelpro® is expected to:increase access to donor-derived stem cell transplantation, which offers a potentially curative option for haematologic malignancies, including leukemias and myelodysplastic syndromesbe...

Osteoarthritis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2025-2034) | DelveInsight

According to DelveInsight's analysis, the current developmental pipeline for osteoarthritis is robust, with several companies initiating clinical trials to investigate new treatment options or...

Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected for residency in the Bayer Co.Lab incubator in Berlin.

Regenerative Medicine Market to Hit USD 115.6 Billion by 2029 | Rising Demand in Dermatology & Orthopedic Fuels 19.2% CAGR | Valuates Reports

BANGALORE, India, June 16, 2025 /PRNewswire/ -- Regenerative Medicine Market is Segmented by Type (Cell Therapy, Tissue Engineering, Biomaterial), by Application (Dermatology, Cardiovascular, CNS, Orthopedic). The...

HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure

NANJING, China, June 16, 2025 /PRNewswire/ -- HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest...

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

               

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCell therapies

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers